Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
04 DE AGO DE 2026Por Administrador FynarkFonte: CNBC
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Fonte original: https://www.cnbc.com/2026/08/04/pfizer-pfe-earnings-q2-2026.html
Notícias relacionadas
Global · 21 DE OUT DE 2026
Iraq closes Sheeb border crossing with Iran to check security, sources say - Reuters
Global · 21 DE OUT DE 2026
UK inflation jumps to highest in nearly a year at 3.5% - Reuters
Global · 21 DE OUT DE 2026
UK approves long-delayed Jackdaw gas field - Reuters
Global · 21 DE OUT DE 2026